﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2023v5.1">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2024-11-12T11:23:37-06:00</ReturnTs>
    <TaxPeriodEndDt>2023-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>341874260</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>CBIZ SLD</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>44 MONTGOMERY ST SUITE 1000</AddressLine1Txt>
        <CityNm>SAN FRANCISCO</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>94104</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990PF</ReturnTypeCd>
    <TaxPeriodBeginDt>2023-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>366049231</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>A FRANK ROTHSCHILD FUND</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>AFRA</BusinessNameControlTxt>
      <PhoneNum>6505299966</PhoneNum>
      <USAddress>
        <AddressLine1Txt>37 MOUNTAIN MEADOW DRIVE</AddressLine1Txt>
        <CityNm>WOODSIDE</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>94062</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>A FRANK ROTHSCHILD</PersonNm>
      <PersonTitleTxt>PRESIDENT</PersonTitleTxt>
      <PhoneNum>6505299966</PhoneNum>
      <SignatureDt>2024-11-11</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>1</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>KEVIN TUSING</PreparerPersonNm>
      <PTIN>P01241383</PTIN>
      <PhoneNum>4153974444</PhoneNum>
      <PreparationDt>2024-11-11</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2023</TaxYr>
    <BuildTS>2024-10-15 13:58:12Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="11">
    <IRS990PF documentId="RetDoc1235000001" referenceDocumentId="RetDoc2258700001">
      <Organization501c3ExemptPFInd>X</Organization501c3ExemptPFInd>
      <FMVAssetsEOYAmt>686834</FMVAssetsEOYAmt>
      <MethodOfAccountingCashInd>X</MethodOfAccountingCashInd>
      <AnalysisOfRevenueAndExpenses>
        <ScheduleBNotRequiredInd>X</ScheduleBNotRequiredInd>
        <InterestOnSavRevAndExpnssAmt>1</InterestOnSavRevAndExpnssAmt>
        <InterestOnSavNetInvstIncmAmt>1</InterestOnSavNetInvstIncmAmt>
        <InterestOnSavingsAdjNetIncmAmt>1</InterestOnSavingsAdjNetIncmAmt>
        <DividendsRevAndExpnssAmt>8993</DividendsRevAndExpnssAmt>
        <DividendsNetInvstIncmAmt>8993</DividendsNetInvstIncmAmt>
        <DividendsAdjNetIncmAmt>8993</DividendsAdjNetIncmAmt>
        <NetGainSaleAstRevAndExpnssAmt>7887</NetGainSaleAstRevAndExpnssAmt>
        <GrossSalesPriceAmt>59526</GrossSalesPriceAmt>
        <CapGainNetIncmNetInvstIncmAmt>7887</CapGainNetIncmNetInvstIncmAmt>
        <NetSTCapitalGainAdjNetIncmAmt>0</NetSTCapitalGainAdjNetIncmAmt>
        <OtherIncomeRevAndExpnssAmt referenceDocumentId="RetDoc2001500001">255000</OtherIncomeRevAndExpnssAmt>
        <OtherIncomeNetInvstIncmAmt>0</OtherIncomeNetInvstIncmAmt>
        <OtherIncomeAdjNetIncmAmt>255000</OtherIncomeAdjNetIncmAmt>
        <TotalRevAndExpnssAmt>271881</TotalRevAndExpnssAmt>
        <TotalNetInvstIncmAmt>16881</TotalNetInvstIncmAmt>
        <TotalAdjNetIncmAmt>263994</TotalAdjNetIncmAmt>
        <CompOfcrDirTrstRevAndExpnssAmt>0</CompOfcrDirTrstRevAndExpnssAmt>
        <CompOfcrDirTrstNetInvstIncmAmt>0</CompOfcrDirTrstNetInvstIncmAmt>
        <CompOfcrDirTrstAdjNetIncmAmt>0</CompOfcrDirTrstAdjNetIncmAmt>
        <CompOfcrDirTrstDsbrsChrtblAmt>0</CompOfcrDirTrstDsbrsChrtblAmt>
        <LegalFeesRevAndExpnssAmt referenceDocumentId="RetDoc2002100001">32055</LegalFeesRevAndExpnssAmt>
        <LegalFeesNetInvstIncmAmt>0</LegalFeesNetInvstIncmAmt>
        <LegalFeesAdjNetIncmAmt>0</LegalFeesAdjNetIncmAmt>
        <LegalFeesDsbrsChrtblAmt>32055</LegalFeesDsbrsChrtblAmt>
        <AccountingFeesRevAndExpnssAmt referenceDocumentId="RetDoc2002200001">7000</AccountingFeesRevAndExpnssAmt>
        <AccountingFeesNetInvstIncmAmt>0</AccountingFeesNetInvstIncmAmt>
        <AccountingFeesAdjNetIncmAmt>7000</AccountingFeesAdjNetIncmAmt>
        <AccountingFeesChrtblPrpsAmt>0</AccountingFeesChrtblPrpsAmt>
        <OtherProfFeesRevAndExpnssAmt referenceDocumentId="RetDoc2002300001">2788</OtherProfFeesRevAndExpnssAmt>
        <OtherProfFeesNetInvstIncmAmt>2788</OtherProfFeesNetInvstIncmAmt>
        <OtherProfFeesAdjNetIncmAmt>2788</OtherProfFeesAdjNetIncmAmt>
        <OtherProfFeesDsbrsChrtblAmt>0</OtherProfFeesDsbrsChrtblAmt>
        <TaxesRevAndExpnssAmt referenceDocumentId="RetDoc2002500001">242</TaxesRevAndExpnssAmt>
        <TaxesNetInvstIncmAmt>0</TaxesNetInvstIncmAmt>
        <TaxesAdjNetIncmAmt>154</TaxesAdjNetIncmAmt>
        <TaxesDsbrsChrtblAmt>0</TaxesDsbrsChrtblAmt>
        <OtherExpensesRevAndExpnssAmt referenceDocumentId="RetDoc2003200001">9276</OtherExpensesRevAndExpnssAmt>
        <OtherExpensesNetInvstIncmAmt>0</OtherExpensesNetInvstIncmAmt>
        <OtherExpensesAdjNetIncmAmt>246</OtherExpensesAdjNetIncmAmt>
        <OtherExpensesDsbrsChrtblAmt>9030</OtherExpensesDsbrsChrtblAmt>
        <TotOprExpensesRevAndExpnssAmt>51361</TotOprExpensesRevAndExpnssAmt>
        <TotOprExpensesNetInvstIncmAmt>2788</TotOprExpensesNetInvstIncmAmt>
        <TotOprExpensesAdjNetIncmAmt>10188</TotOprExpensesAdjNetIncmAmt>
        <TotOprExpensesDsbrsChrtblAmt>41085</TotOprExpensesDsbrsChrtblAmt>
        <ContriPaidRevAndExpnssAmt>0</ContriPaidRevAndExpnssAmt>
        <ContriPaidDsbrsChrtblAmt>0</ContriPaidDsbrsChrtblAmt>
        <TotalExpensesRevAndExpnssAmt>51361</TotalExpensesRevAndExpnssAmt>
        <TotalExpensesNetInvstIncmAmt>2788</TotalExpensesNetInvstIncmAmt>
        <TotalExpensesAdjNetIncmAmt>10188</TotalExpensesAdjNetIncmAmt>
        <TotalExpensesDsbrsChrtblAmt>41085</TotalExpensesDsbrsChrtblAmt>
        <ExcessRevenueOverExpensesAmt>220520</ExcessRevenueOverExpensesAmt>
        <NetInvestmentIncomeAmt>14093</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>253806</AdjustedNetIncomeAmt>
      </AnalysisOfRevenueAndExpenses>
      <Form990PFBalanceSheetsGrp>
        <CashBOYAmt>8743</CashBOYAmt>
        <CashEOYAmt>20170</CashEOYAmt>
        <CashEOYFMVAmt>20170</CashEOYFMVAmt>
        <SavAndTempCashInvstBOYAmt>5893</SavAndTempCashInvstBOYAmt>
        <SavAndTempCashInvstEOYAmt>1307</SavAndTempCashInvstEOYAmt>
        <SavAndTempCashInvstEOYFMVAmt>1307</SavAndTempCashInvstEOYFMVAmt>
        <OtherNtsAndLoansRcvblAmt>250000</OtherNtsAndLoansRcvblAmt>
        <OtherRcvblAllwncDbtflAcctAmt>0</OtherRcvblAllwncDbtflAcctAmt>
        <OtherNtsAndLoansRcvblBOYAmt>0</OtherNtsAndLoansRcvblBOYAmt>
        <OtherNtsAndLoansRcvblEOYAmt>250000</OtherNtsAndLoansRcvblEOYAmt>
        <OtherNtsAndLoansRcvblEOYFMVAmt>250000</OtherNtsAndLoansRcvblEOYFMVAmt>
        <CorporateStockBOYAmt>156522</CorporateStockBOYAmt>
        <CorporateStockEOYAmt referenceDocumentId="RetDoc2018900001">149577</CorporateStockEOYAmt>
        <CorporateStockEOYFMVAmt>365342</CorporateStockEOYFMVAmt>
        <CorporateBondsBOYAmt>84109</CorporateBondsBOYAmt>
        <CorporateBondsEOYAmt referenceDocumentId="RetDoc2044400001">54762</CorporateBondsEOYAmt>
        <CorporateBondsEOYFMVAmt>50015</CorporateBondsEOYFMVAmt>
        <LandBldgEquipCostOrOtherBssAmt>51797</LandBldgEquipCostOrOtherBssAmt>
        <LandBldgEquipAccumDeprecAmt>51797</LandBldgEquipAccumDeprecAmt>
        <OtherAssetsBOYAmt referenceDocumentId="RetDoc2046600001">29</OtherAssetsBOYAmt>
        <OtherAssetsEOYAmt referenceDocumentId="RetDoc2046600001">0</OtherAssetsEOYAmt>
        <OtherAssetsEOYFMVAmt referenceDocumentId="RetDoc2046600001">0</OtherAssetsEOYFMVAmt>
        <TotalAssetsBOYAmt>255296</TotalAssetsBOYAmt>
        <TotalAssetsEOYAmt>475816</TotalAssetsEOYAmt>
        <TotalAssetsEOYFMVAmt>686834</TotalAssetsEOYFMVAmt>
        <TotalLiabilitiesBOYAmt>0</TotalLiabilitiesBOYAmt>
        <TotalLiabilitiesEOYAmt>0</TotalLiabilitiesEOYAmt>
        <OrgDoesNotFollowFASB117Ind>X</OrgDoesNotFollowFASB117Ind>
        <CapitalStockBOYAmt>255296</CapitalStockBOYAmt>
        <CapitalStockEOYAmt>475816</CapitalStockEOYAmt>
        <AdditionalPaidInCapitalBOYAmt>0</AdditionalPaidInCapitalBOYAmt>
        <AdditionalPaidInCapitalEOYAmt>0</AdditionalPaidInCapitalEOYAmt>
        <RetainedEarningBOYAmt>0</RetainedEarningBOYAmt>
        <RetainedEarningEOYAmt>0</RetainedEarningEOYAmt>
        <TotNetAstOrFundBalancesBOYAmt>255296</TotNetAstOrFundBalancesBOYAmt>
        <TotNetAstOrFundBalancesEOYAmt>475816</TotNetAstOrFundBalancesEOYAmt>
        <TotalLiabilitiesNetAstBOYAmt>255296</TotalLiabilitiesNetAstBOYAmt>
        <TotalLiabilitiesNetAstEOYAmt>475816</TotalLiabilitiesNetAstEOYAmt>
      </Form990PFBalanceSheetsGrp>
      <ChgInNetAssetsFundBalancesGrp>
        <TotNetAstOrFundBalancesBOYAmt>255296</TotNetAstOrFundBalancesBOYAmt>
        <ExcessRevenueOverExpensesAmt>220520</ExcessRevenueOverExpensesAmt>
        <OtherIncreasesAmt>0</OtherIncreasesAmt>
        <SubtotalAmt>475816</SubtotalAmt>
        <OtherDecreasesAmt>0</OtherDecreasesAmt>
        <TotNetAstOrFundBalancesEOYAmt>475816</TotNetAstOrFundBalancesEOYAmt>
      </ChgInNetAssetsFundBalancesGrp>
      <CapGainsLossTxInvstIncmDetail>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>TIME WARNER CAB 8.375XXX**MATURED**</PropertyDesc>
          <AcquiredDt>2013-10-03</AcquiredDt>
          <SoldDt>2023-03-15</SoldDt>
          <GrossSalesPriceAmt>25000</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>29347</CostOrOtherBasisAmt>
          <GainOrLossAmt>-4347</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-4347</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>50 SHS NVIDIA CORP</PropertyDesc>
          <AcquiredDt>2019-02-25</AcquiredDt>
          <SoldDt>2023-06-05</SoldDt>
          <GrossSalesPriceAmt>19641</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>1992</CostOrOtherBasisAmt>
          <GainOrLossAmt>17649</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>17649</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapGainsLossTxInvstIncmGrp>
          <PropertyDesc>200 SHS RTX CORP</PropertyDesc>
          <AcquiredDt>2022-03-23</AcquiredDt>
          <SoldDt>2023-09-19</SoldDt>
          <GrossSalesPriceAmt>14885</GrossSalesPriceAmt>
          <CostOrOtherBasisAmt>20300</CostOrOtherBasisAmt>
          <GainOrLossAmt>-5415</GainOrLossAmt>
          <GainsMinusExcessOrLossesAmt>-5415</GainsMinusExcessOrLossesAmt>
        </CapGainsLossTxInvstIncmGrp>
        <CapitalGainNetIncomeAmt>7887</CapitalGainNetIncomeAmt>
        <NetShortTermCapitalGainLossAmt>0</NetShortTermCapitalGainLossAmt>
      </CapGainsLossTxInvstIncmDetail>
      <ExciseTaxBasedOnInvstIncmGrp>
        <InvestmentIncomeExciseTaxAmt>196</InvestmentIncomeExciseTaxAmt>
        <TaxUnderSection511Amt>0</TaxUnderSection511Amt>
        <SubtotalAmt>196</SubtotalAmt>
        <SubtitleATaxAmt>0</SubtitleATaxAmt>
        <TaxBasedOnInvestmentIncomeAmt>196</TaxBasedOnInvestmentIncomeAmt>
        <EstimatedPlusOvpmtIncmTxAmt>0</EstimatedPlusOvpmtIncmTxAmt>
        <ExemptFrgnOrgTaxWthldAtSrceAmt>0</ExemptFrgnOrgTaxWthldAtSrceAmt>
        <ExtsnRequestIncomeTaxPaidAmt>0</ExtsnRequestIncomeTaxPaidAmt>
        <BackupWithholdingWithheldAmt>0</BackupWithholdingWithheldAmt>
        <TotalPaymentsAndCreditsAmt>0</TotalPaymentsAndCreditsAmt>
        <EsPenaltyAmt>0</EsPenaltyAmt>
        <TaxDueAmt>196</TaxDueAmt>
      </ExciseTaxBasedOnInvstIncmGrp>
      <StatementsRegardingActyGrp>
        <LegislativePoliticalActyInd>0</LegislativePoliticalActyInd>
        <MoreThan100SpentInd>0</MoreThan100SpentInd>
        <Form1120POLFiledInd>0</Form1120POLFiledInd>
        <Section4955OrganizationTaxAmt>0</Section4955OrganizationTaxAmt>
        <Section4955ManagersTaxAmt>0</Section4955ManagersTaxAmt>
        <TaxReimbursedAmt>0</TaxReimbursedAmt>
        <ActivitiesNotPreviouslyRptInd>0</ActivitiesNotPreviouslyRptInd>
        <ChangesToArticlesOrBylawsInd>0</ChangesToArticlesOrBylawsInd>
        <UnrelatedBusIncmOverLimitInd>0</UnrelatedBusIncmOverLimitInd>
        <OrganizationDissolvedEtcInd>0</OrganizationDissolvedEtcInd>
        <Section508eRqrSatisfiedInd>1</Section508eRqrSatisfiedInd>
        <AtLeast5000InAssetsInd>1</AtLeast5000InAssetsInd>
        <OrgReportOrRegisterStateCd>IL</OrgReportOrRegisterStateCd>
        <OrgReportOrRegisterStateCd>CA</OrgReportOrRegisterStateCd>
        <Form990PFFiledWithAttyGenInd>1</Form990PFFiledWithAttyGenInd>
        <PrivateOperatingFoundationInd>1</PrivateOperatingFoundationInd>
        <NewSubstantialContributorsInd>0</NewSubstantialContributorsInd>
        <OwnControlledEntityInd>0</OwnControlledEntityInd>
        <DonorAdvisedFundInd>0</DonorAdvisedFundInd>
        <ComplyWithPublicInspRqrInd>1</ComplyWithPublicInspRqrInd>
        <WebsiteAddressTxt>N/A</WebsiteAddressTxt>
        <IndividualWithBooksNm>A FRANK ROTHSCHILD</IndividualWithBooksNm>
        <PhoneNum>6505299966</PhoneNum>
        <LocationOfBooksUSAddress>
          <AddressLine1Txt>37 MOUNTAIN MEADOW DRIVE</AddressLine1Txt>
          <CityNm>WOODSIDE</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>94062</ZIPCd>
        </LocationOfBooksUSAddress>
        <ForeignAccountsQuestionInd>0</ForeignAccountsQuestionInd>
      </StatementsRegardingActyGrp>
      <StatementsRegardingActy4720Grp>
        <SaleOrExchDisqualifiedPrsnInd>0</SaleOrExchDisqualifiedPrsnInd>
        <BrrwOrLendDisqualifiedPrsnInd>0</BrrwOrLendDisqualifiedPrsnInd>
        <FurnGoodsDisqualifiedPrsnInd>0</FurnGoodsDisqualifiedPrsnInd>
        <PayCompDisqualifiedPrsnInd>0</PayCompDisqualifiedPrsnInd>
        <TransferAstDisqualifiedPrsnInd>0</TransferAstDisqualifiedPrsnInd>
        <PaymentToGovernmentOfficialInd>0</PaymentToGovernmentOfficialInd>
        <UncorrectedPriorActsInd>0</UncorrectedPriorActsInd>
        <UndistributedIncomePYInd>0</UndistributedIncomePYInd>
        <BusinessHoldingsInd>0</BusinessHoldingsInd>
        <JeopardyInvestmentsInd>0</JeopardyInvestmentsInd>
        <UncorrectedPYJeopardyInvstInd>0</UncorrectedPYJeopardyInvstInd>
        <InfluenceLegislationInd>0</InfluenceLegislationInd>
        <InfluenceElectionInd>0</InfluenceElectionInd>
        <GrantsToIndividualsInd>0</GrantsToIndividualsInd>
        <GrantsToOrganizationsInd>0</GrantsToOrganizationsInd>
        <NoncharitablePurposeInd>0</NoncharitablePurposeInd>
        <TransactionsFailToQlfyAsExcInd>0</TransactionsFailToQlfyAsExcInd>
        <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
        <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
        <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
        <SubjToTaxRmnrtnExPrchtPymtInd>0</SubjToTaxRmnrtnExPrchtPymtInd>
      </StatementsRegardingActy4720Grp>
      <OfficerDirTrstKeyEmplInfoGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>A FRANK ROTHSCHILD</PersonNm>
          <USAddress>
            <AddressLine1Txt>37 MOUNTAIN MEADOW DRIVE</AddressLine1Txt>
            <CityNm>WOODSIDE</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94062</ZIPCd>
          </USAddress>
          <TitleTxt>PRES &amp; TREASURE</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>40.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <OfficerDirTrstKeyEmplGrp>
          <PersonNm>PHILIP A HART</PersonNm>
          <USAddress>
            <AddressLine1Txt>201 MISSION STREET SUITE 1825</AddressLine1Txt>
            <CityNm>SAN FRANCISCO</CityNm>
            <StateAbbreviationCd>CA</StateAbbreviationCd>
            <ZIPCd>94105</ZIPCd>
          </USAddress>
          <TitleTxt>SECRETARY &amp; VP</TitleTxt>
          <AverageHrsPerWkDevotedToPosRt>1.00</AverageHrsPerWkDevotedToPosRt>
          <CompensationAmt>0</CompensationAmt>
          <EmployeeBenefitProgramAmt>0</EmployeeBenefitProgramAmt>
          <ExpenseAccountOtherAllwncAmt>0</ExpenseAccountOtherAllwncAmt>
        </OfficerDirTrstKeyEmplGrp>
        <CompOfHghstPdEmplOrNONETxt>NONE</CompOfHghstPdEmplOrNONETxt>
        <OtherEmployeePaidOver50kCnt>0</OtherEmployeePaidOver50kCnt>
        <CompOfHghstPdCntrctOrNONETxt>NONE</CompOfHghstPdCntrctOrNONETxt>
        <ContractorPaidOver50kCnt>0</ContractorPaidOver50kCnt>
      </OfficerDirTrstKeyEmplInfoGrp>
      <SummaryOfDirectChrtblActyGrp>
        <Description1Txt>THE A. F. ROTHSCHILD FUND IS AN INDEPENDENT PRIVATE OPERATING FOUNDATION DEDICATED TO THE WELL-BEING AND PROTECTION OF HORSES, DONKEYS, AND THEIR KIN. THE FUND DIRECTLY ENGAGES IN INITIATION, DEVELOPMENT, AND IMPLEMENTATION OF EQUINE-SPECIFIC SCIENTIFIC RESEARCH, LEGAL INTERVENTION, ACADEMIC SCHOLARSHIP AND RELATED EDUCATIONAL PROJECTS AS PROGRAM INITIATIVES OF THE CENTER FOR CONTEMPORARY EQUINE STUDIES (CCES), A SUPPORTING ORGANIZATION HEADQUARTERED IN WOODSIDE,CA.PRINCIPAL DIRECT ACTIVITIES DURING 2023 INCLUDED:1. HALTING AMAZON INC.'S UNLAWFUL ONLINE SALES IN CALIFORNIA OF "EJIAO," A PURPORTEDLY ANCIENT TRADITIONAL CHINESE MEDICINE DERIVED FROM THE SKIN OF SLAUGHTERED DONKEYS MARKETED IN VARIOUS FORMS AS AN HERBAL FOOD SUPPLEMENT/ NUTRACEUTICAL. AMAZON IS ONE OF NUMEROUS DEFENDANTS NAMED IN THE FUND'S PRECENDENTIAL LAWSUIT FILED IN 2022 FOR ADJUDICATION BY THE CA SUPERIOR COURT TO ENFORCE STATE PROPOSITION 6 PROHIBITING THE SALE OF EQUINE MEAT CONTINUED ON STATEMENT 18</Description1Txt>
        <Expenses1Amt>32055</Expenses1Amt>
        <Description2Txt>PEER REVIEW PUBLICATIONS AND CONFERENCE PRESENTATIONS (PARTIAL):PUCCA, M.B.&amp; CAMPHORA, A.L. "THE POTENTIAL RISKS OF EQUINE SERUM THERAPY IN TRANSMITTING NEW INFECTIOUS DISEASES: LESSONS FROM A POST- PANDEMIC ERA." FRONTIERS IN PUBLIC HEALTH (ACCEPTED FOR PUBLICATION IN FEB. 2024, VOL 12).CAMPHORA, A.L. "EQUINE USE IN MODERN MEDICINE" LATIN AMERICAN JOURNAL OF CRITICAL ANIMAL STUDIES, 2023 9(2).CAMPHORA, A.L. &amp; CASTRO, D. "PRODUCTION OF EQUINE GONADOTROPIC HORMONE AT SYNTEX S.A. 'BLOOD FARMS'"(SOUTHERN CONE OF LATIN AMERICA): DON'T LOOK DOWN!" LATIN AMERICAN JOURNAL OF CRITICAL ANIMAL STUDIES, 2023 9(2).INVITED PARTICIPANT - XVII CONGRESS OF THE BRAZILIAN SOCIETY OF TOXINOLOGY/XIII CONGRESS OF THE PAN AMERICAN SECTION OF THE INTERNATIONAL SOCIETY OF TOXINOLOGY, NOV. 9-13, 2023.</Description2Txt>
        <Expenses2Amt>9030</Expenses2Amt>
      </SummaryOfDirectChrtblActyGrp>
      <SumOfProgramRelatedInvstGrp>
        <TotalAmt>0</TotalAmt>
      </SumOfProgramRelatedInvstGrp>
      <MinimumInvestmentReturnGrp>
        <AverageMonthlyFMVOfSecAmt>392895</AverageMonthlyFMVOfSecAmt>
        <AverageMonthlyCashBalancesAmt>23556</AverageMonthlyCashBalancesAmt>
        <FMVAllOtherNoncharitableAstAmt>0</FMVAllOtherNoncharitableAstAmt>
        <TotalFMVOfUnusedAssetsAmt>416451</TotalFMVOfUnusedAssetsAmt>
        <ReductionClaimedAmt>0</ReductionClaimedAmt>
        <AcquisitionIndebtednessAmt>0</AcquisitionIndebtednessAmt>
        <AdjustedTotalFMVOfUnusedAstAmt>416451</AdjustedTotalFMVOfUnusedAstAmt>
        <CashDeemedCharitableAmt>6247</CashDeemedCharitableAmt>
        <NetVlNoncharitableAssetsAmt>410204</NetVlNoncharitableAssetsAmt>
        <MinimumInvestmentReturnAmt>20510</MinimumInvestmentReturnAmt>
      </MinimumInvestmentReturnGrp>
      <DistributableAmountGrp>
        <Sect4942j3j5FndtnAndFrgnOrgInd>X</Sect4942j3j5FndtnAndFrgnOrgInd>
      </DistributableAmountGrp>
      <PFQualifyingDistributionsGrp>
        <ExpensesAndContributionsAmt>41085</ExpensesAndContributionsAmt>
        <ProgramRelatedInvstTotalAmt>0</ProgramRelatedInvstTotalAmt>
        <QualifyingDistributionsAmt>41085</QualifyingDistributionsAmt>
      </PFQualifyingDistributionsGrp>
      <PrivateOperatingFoundationsGrp>
        <PrivateOperatingFndtnRulingDt>2010-03-18</PrivateOperatingFndtnRulingDt>
        <Section4942j3Ind>X</Section4942j3Ind>
        <LessorAdjNetIncmMinInvstRetGrp>
          <CurrentYearAmt>20510</CurrentYearAmt>
          <Year1Amt>2117</Year1Amt>
          <Year2Amt>5258</Year2Amt>
          <Year3Amt>1704</Year3Amt>
          <TotalAmt>29589</TotalAmt>
        </LessorAdjNetIncmMinInvstRetGrp>
        <Pct85LessorAdjIncmOrMinRetGrp>
          <CurrentYearAmt>17434</CurrentYearAmt>
          <Year1Amt>1799</Year1Amt>
          <Year2Amt>4469</Year2Amt>
          <Year3Amt>1448</Year3Amt>
          <TotalAmt>25151</TotalAmt>
        </Pct85LessorAdjIncmOrMinRetGrp>
        <QualifyingDistributionsGrp>
          <CurrentYearAmt>41085</CurrentYearAmt>
          <Year1Amt>31344</Year1Amt>
          <Year2Amt>6795</Year2Amt>
          <Year3Amt>0</Year3Amt>
          <TotalAmt>79224</TotalAmt>
        </QualifyingDistributionsGrp>
        <QualifyingDistriNotUsedDrtGrp>
          <CurrentYearAmt>0</CurrentYearAmt>
          <Year1Amt>0</Year1Amt>
          <Year2Amt>0</Year2Amt>
          <Year3Amt>0</Year3Amt>
          <TotalAmt>0</TotalAmt>
        </QualifyingDistriNotUsedDrtGrp>
        <QualifyingDistriMadeDrtGrp>
          <CurrentYearAmt>41085</CurrentYearAmt>
          <Year1Amt>31344</Year1Amt>
          <Year2Amt>6795</Year2Amt>
          <Year3Amt>0</Year3Amt>
          <TotalAmt>79224</TotalAmt>
        </QualifyingDistriMadeDrtGrp>
        <TotalAssetsGrp>
          <TotalAmt>0</TotalAmt>
        </TotalAssetsGrp>
        <TotalAssetsSect4942j3BiGrp>
          <TotalAmt>0</TotalAmt>
        </TotalAssetsSect4942j3BiGrp>
        <TwoThirdsMinimumInvstRetGrp>
          <CurrentYearAmt>13673</CurrentYearAmt>
          <Year1Amt>13405</Year1Amt>
          <Year2Amt>14371</Year2Amt>
          <Year3Amt>11851</Year3Amt>
          <TotalAmt>53300</TotalAmt>
        </TwoThirdsMinimumInvstRetGrp>
        <TotalSupportGrp>
          <TotalAmt>0</TotalAmt>
        </TotalSupportGrp>
        <PublicSupportType>
          <TotalAmt>0</TotalAmt>
        </PublicSupportType>
        <LargestSupportFromEOGrp>
          <TotalAmt>0</TotalAmt>
        </LargestSupportFromEOGrp>
        <GrossInvestmentIncomeGrp>
          <TotalAmt>0</TotalAmt>
        </GrossInvestmentIncomeGrp>
      </PrivateOperatingFoundationsGrp>
      <SupplementaryInformationGrp>
        <OnlyContriToPreselectedInd>X</OnlyContriToPreselectedInd>
        <TotalGrantOrContriPdDurYrAmt>0</TotalGrantOrContriPdDurYrAmt>
        <TotalGrantOrContriApprvFutAmt>0</TotalGrantOrContriApprvFutAmt>
      </SupplementaryInformationGrp>
      <AnalysisIncomeProducingActyGrp>
        <IntOnSavAndTempCashInvstGrp>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>1</ExclusionAmt>
        </IntOnSavAndTempCashInvstGrp>
        <DividendsAndInterestFromSecDtl>
          <ExclusionCd>14</ExclusionCd>
          <ExclusionAmt>8993</ExclusionAmt>
        </DividendsAndInterestFromSecDtl>
        <GainSalesAstOthThanInvntryGrp>
          <ExclusionCd>18</ExclusionCd>
          <ExclusionAmt>7887</ExclusionAmt>
        </GainSalesAstOthThanInvntryGrp>
        <OtherRevenueDescribedGrp>
          <Desc>LAWSUIT SETTLEMENT</Desc>
          <RelatedOrExemptFunctionIncmAmt>5000</RelatedOrExemptFunctionIncmAmt>
        </OtherRevenueDescribedGrp>
        <OtherRevenueDescribedGrp>
          <Desc>REFUND OF GRANT</Desc>
          <RelatedOrExemptFunctionIncmAmt>250000</RelatedOrExemptFunctionIncmAmt>
        </OtherRevenueDescribedGrp>
        <SubtotalsIncmProducingActyGrp>
          <UnrelatedBusinessTaxblIncmAmt>0</UnrelatedBusinessTaxblIncmAmt>
          <ExclusionAmt>16881</ExclusionAmt>
          <RelatedOrExemptFunctionIncmAmt>255000</RelatedOrExemptFunctionIncmAmt>
        </SubtotalsIncmProducingActyGrp>
        <TotalIncomeProducingActyAmt>271881</TotalIncomeProducingActyAmt>
      </AnalysisIncomeProducingActyGrp>
      <RlnOfActyToAccomOfExmptPrpsGrp>
        <RlnOfActyToAccomOfExmptPrpsGrp>
          <LineNumberTxt>3</LineNumberTxt>
          <RelationshipStatementTxt>N/A</RelationshipStatementTxt>
        </RlnOfActyToAccomOfExmptPrpsGrp>
        <RlnOfActyToAccomOfExmptPrpsGrp>
          <LineNumberTxt>4</LineNumberTxt>
          <RelationshipStatementTxt>N/A</RelationshipStatementTxt>
        </RlnOfActyToAccomOfExmptPrpsGrp>
        <RlnOfActyToAccomOfExmptPrpsGrp>
          <LineNumberTxt>8</LineNumberTxt>
          <RelationshipStatementTxt>N/A</RelationshipStatementTxt>
        </RlnOfActyToAccomOfExmptPrpsGrp>
      </RlnOfActyToAccomOfExmptPrpsGrp>
      <TrnsfrTransRlnNonchrtblEOGrp>
        <TrnsfrOfCashToNonchrtblEOInd>0</TrnsfrOfCashToNonchrtblEOInd>
        <TrnsfrOtherAssetNonchrtblEOInd>0</TrnsfrOtherAssetNonchrtblEOInd>
        <SalesOrExchangesOfAssetsInd>0</SalesOrExchangesOfAssetsInd>
        <PurchaseOfAssetsNonchrtblEOInd>0</PurchaseOfAssetsNonchrtblEOInd>
        <RentalOfFacilitiesOthAssetsInd>0</RentalOfFacilitiesOthAssetsInd>
        <ReimbursementArrangementsInd>0</ReimbursementArrangementsInd>
        <LoansOrLoanGuaranteesInd>0</LoansOrLoanGuaranteesInd>
        <PerformanceOfServicesEtcInd>0</PerformanceOfServicesEtcInd>
        <SharingOfFacilitiesEtcInd>0</SharingOfFacilitiesEtcInd>
        <RelationshipsNonchrtblEOInd>0</RelationshipsNonchrtblEOInd>
      </TrnsfrTransRlnNonchrtblEOGrp>
    </IRS990PF>
    <AccountingFeesSchedule documentId="RetDoc2002200001">
      <AccountingFeesDetail>
        <CategoryTxt>TAX PREPERATION</CategoryTxt>
        <Amt>7000</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>7000</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </AccountingFeesDetail>
    </AccountingFeesSchedule>
    <GeneralExplanationAttachment documentId="RetDoc2258700001">
      <GeneralExplanationGrp>
        <IdentifierTxt>CONTINUATION OF SUMMARY OF DIRECT CHARITABLE ACTIVITIES DESCRIPTION</IdentifierTxt>
        <FormAndLineReferenceDesc>FORM 990-PF, PART VIII-A SUMMARY OF DIRECT CHARITABLE ACTIVITIES</FormAndLineReferenceDesc>
        <MediumExplanationTxt>CONTINUED FROM STATEMENT 16FOR HUMAN CONSUMPTION, AND STANDS AS THE FIRST JUDICIAL CASE SINCE THE 1989 BALLOT INITIATIVE WAS PASSED INTO LAW 25 YEARS AGO. THE FUND'S LAWSUIT IS PRESENTLY PENDING COURT SCHEDULING FOR SUMMARY JUDGEMENT TENTATIVELY DOCKETED FOR NOV. 2024.2. CONTINUED CRITICAL INVESTIGATION OF THE GLOBAL EQUINE SERUM INDUSTRY FOCUSING PRIMARILY ON BRAZIL AS THE LARGEST NATIONAL MANUFACTURER IN THE WESTERN HEMISPHERE OF PHARMACEUTICALS BASED ON THE ARCHAIC INDUSTRIAL USE OF HORSES AS LIVING INCUBATORS FOR BIOLOGICAL MASS PRODUCTION OF ANTIVENOMS, ANTITOXINS, IMMUNE SERUMS AND OTHER ANTIBODY-BASED DRUG PRODUCTS - A SCIENTIFICALLY OBSOLETE AND ETHICALLY UNACCEPTABLE 19TH CENTURY FORM OF "BIOTECHNOLOGY" KNOWN TO INFLICT SEVERE, AGONIZING AND ROUTINELY FATAL SYSTEMIC DEGENERATION AND IRREVERSIBLE ORGAN DAMAGE AS INHERENT EFFECT OF THE PROCEDURES AND WHICH HAVE BEEN WITHHELD FROM PUBLIC DISCLOSURE SINCE THE PROCEDURE WAS FIRST DEPLOYED IN 1896 BY THE PASTEUR INSTITUTE TO FACILITATE LARGE-SCALE MANUFACTURE OF THE DIPHTHERIA ANTITOXIN. THE INVESTIGATIVE RESEARCH, BEGUN IN 2010, IS CONCOMITANT WITH THE FUND'S ONGOING DEVELOPMENT OF NOVEL HUMAN RECOMBINANT ALTERNATIVES IN COLLABORATION WITH THE PETA INTERNATIONAL SCIENCE CONSORTIUM, INITIATED IN 2012.3. EXTENDING THE FUND'S INVESTIGATIVE RESEARCH TO INCLUDE ON-SITE SURVEY OF THE CONDITIONS AND TREATMENT OF AN ESTIMATED 10,000 MARES IN THE "BLOOD FARMS" OF ARGENTINA AND URUGUAY USED TO PRODUCE EQUINE CHORIONIC GONADOTROPIN, A HORMONE FORCEABLY EXTRACTED FROM THE BLOOD SERUM OF PREGNANT MARES DURING THE FIRST THIRD OF GESTATION AND SOLD WORDWIDE AS A COMMERCIAL AGRICULTURE PRODUCT SINCE 1939 TO INCREASE REPRODUCTION OF FACTORY FARMED ANIMALS, TYPICALLY PIGS. THOUGH EXTENSIVELY DOCUMENTED PUBLICLY DURING THE PAST 8 YEARS BY THE ANIMAL WELFARE FOUNDATION AND TIERSCHUTZBUND ZURICH, THE ROUTINE BRUTALITY, ABUSE AND DEATHS OF THE MARES AND SLAUGHTER OF THEIR FOALS AS BY- PRODUCTS REMAINS VIRUALLY NEGLECTED IN THE US AND POORLY REGULATED IN THE NUMEROUS COUNTRIES WHERE THE BLOOD FARMS EXIST.</MediumExplanationTxt>
      </GeneralExplanationGrp>
    </GeneralExplanationAttachment>
    <InvestmentsCorpBondsSchedule documentId="RetDoc2044400001">
      <InvestmentsCorporateBondsGrp>
        <BondNm>APPLE INC AT 3.35% DUE 2/9/2027</BondNm>
        <EOYBookValueAmt>25534</EOYBookValueAmt>
        <EOYFMVAmt>24353</EOYFMVAmt>
      </InvestmentsCorporateBondsGrp>
      <InvestmentsCorporateBondsGrp>
        <BondNm>FORD MOTOR COMPANY DUE 8/1/2026</BondNm>
        <EOYBookValueAmt>29228</EOYBookValueAmt>
        <EOYFMVAmt>25662</EOYFMVAmt>
      </InvestmentsCorporateBondsGrp>
    </InvestmentsCorpBondsSchedule>
    <InvestmentsCorpStockSchedule documentId="RetDoc2018900001">
      <InvestmentsCorporateStockGrp>
        <StockNm>100 SHS CME GROUP INC</StockNm>
        <EOYBookValueAmt>10167</EOYBookValueAmt>
        <EOYFMVAmt>21060</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>100 SHS WALT DISNEY CO</StockNm>
        <EOYBookValueAmt>10042</EOYBookValueAmt>
        <EOYFMVAmt>9029</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>105 SH ZOETIS INC.</StockNm>
        <EOYBookValueAmt>14958</EOYBookValueAmt>
        <EOYFMVAmt>20724</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>130 SHS VISA INC</StockNm>
        <EOYBookValueAmt>10198</EOYBookValueAmt>
        <EOYFMVAmt>33846</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>160 SH VERIZON COMMUNICATIONS</StockNm>
        <EOYBookValueAmt>9110</EOYBookValueAmt>
        <EOYFMVAmt>6032</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>160 SHS MERCK &amp; CO INC</StockNm>
        <EOYBookValueAmt>9495</EOYBookValueAmt>
        <EOYFMVAmt>17443</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>170 SHS NVIDIA CORP</StockNm>
        <EOYBookValueAmt>6772</EOYBookValueAmt>
        <EOYFMVAmt>84187</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>260 SH COMCAST CORP</StockNm>
        <EOYBookValueAmt>10053</EOYBookValueAmt>
        <EOYFMVAmt>11401</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>330 SHS CISCO SYS INC</StockNm>
        <EOYBookValueAmt>9884</EOYBookValueAmt>
        <EOYFMVAmt>16672</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>360 SHS APPLE INC</StockNm>
        <EOYBookValueAmt>9531</EOYBookValueAmt>
        <EOYFMVAmt>69311</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>400 SHS SCHWAB US MID CAP ETF</StockNm>
        <EOYBookValueAmt>17360</EOYBookValueAmt>
        <EOYFMVAmt>30128</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>75 SHS TRAVELERS COMPANIES INC</StockNm>
        <EOYBookValueAmt>8705</EOYBookValueAmt>
        <EOYFMVAmt>14287</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>80 SH RESMED INC</StockNm>
        <EOYBookValueAmt>7956</EOYBookValueAmt>
        <EOYFMVAmt>13762</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
      <InvestmentsCorporateStockGrp>
        <StockNm>125 ALPHABET INC.</StockNm>
        <EOYBookValueAmt>15346</EOYBookValueAmt>
        <EOYFMVAmt>17460</EOYFMVAmt>
      </InvestmentsCorporateStockGrp>
    </InvestmentsCorpStockSchedule>
    <LegalFeesSchedule documentId="RetDoc2002100001">
      <LegalFeesGrp>
        <CategoryTxt>LEGAL FEES/ DUES</CategoryTxt>
        <LegalFeesAmt>32055</LegalFeesAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>32055</DisbursementsCharitablePrpsAmt>
      </LegalFeesGrp>
    </LegalFeesSchedule>
    <OtherAssetsSchedule documentId="RetDoc2046600001">
      <OtherAssetsScheduleGrp>
        <Desc>DIVIDENDS IN TRANSIT AT YEAR END</Desc>
        <BOYBookValueAmt>29</BOYBookValueAmt>
        <EOYBookValueAmt>0</EOYBookValueAmt>
        <EOYFMVAmt>0</EOYFMVAmt>
      </OtherAssetsScheduleGrp>
    </OtherAssetsSchedule>
    <OtherExpensesSchedule documentId="RetDoc2003200001">
      <OtherExpensesScheduleGrp>
        <Desc>FUNDED RESEARCH</Desc>
        <RevenueAndExpensesPerBooksAmt>9030</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>9030</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>SUBSCRIPTION</Desc>
        <RevenueAndExpensesPerBooksAmt>150</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>150</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>INTERNET AND IT</Desc>
        <RevenueAndExpensesPerBooksAmt>54</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>54</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
      <OtherExpensesScheduleGrp>
        <Desc>POSTAGE</Desc>
        <RevenueAndExpensesPerBooksAmt>42</RevenueAndExpensesPerBooksAmt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>42</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherExpensesScheduleGrp>
    </OtherExpensesSchedule>
    <OtherIncomeSchedule2 documentId="RetDoc2001500001">
      <OtherIncomeDetail>
        <Desc>LAWSUIT SETTLEMENT</Desc>
        <RevenueAndExpensesPerBooksAmt>5000</RevenueAndExpensesPerBooksAmt>
        <AdjustedNetIncomeAmt>5000</AdjustedNetIncomeAmt>
      </OtherIncomeDetail>
      <OtherIncomeDetail>
        <Desc>REFUND OF GRANT</Desc>
        <RevenueAndExpensesPerBooksAmt>250000</RevenueAndExpensesPerBooksAmt>
        <AdjustedNetIncomeAmt>250000</AdjustedNetIncomeAmt>
      </OtherIncomeDetail>
    </OtherIncomeSchedule2>
    <OtherProfessionalFeesSchedule documentId="RetDoc2002300001">
      <OtherProfessionalFeesDetail>
        <CategoryTxt>INVESTMENT MANGEMENT FEES</CategoryTxt>
        <Amt>2788</Amt>
        <NetInvestmentIncomeAmt>2788</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>2788</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </OtherProfessionalFeesDetail>
    </OtherProfessionalFeesSchedule>
    <TaxesSchedule documentId="RetDoc2002500001">
      <TaxesDetail>
        <CategoryTxt>FEDERAL TAXES</CategoryTxt>
        <Amt>88</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>0</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </TaxesDetail>
      <TaxesDetail>
        <CategoryTxt>CALIFORNIA FILING FEES</CategoryTxt>
        <Amt>25</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>25</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </TaxesDetail>
      <TaxesDetail>
        <CategoryTxt>IL AND CA FILING FEES</CategoryTxt>
        <Amt>129</Amt>
        <NetInvestmentIncomeAmt>0</NetInvestmentIncomeAmt>
        <AdjustedNetIncomeAmt>129</AdjustedNetIncomeAmt>
        <DisbursementsCharitablePrpsAmt>0</DisbursementsCharitablePrpsAmt>
      </TaxesDetail>
    </TaxesSchedule>
  </ReturnData>
</Return>